This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A 15-year-old receives the Pfizer-BioNTech vaccine against the CCP virus in Bloomfield Hills, Mich., on May 13, 2021. Jeff Kowalsky/AFP via Getty Images
Britain’s medicines regulator said on Friday that it has approved the use of the Pfizer/BioNTech CCP virus vaccine in 12 to 15-year-olds.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the decision follows a “rigorous review” of safety and effectiveness in that age group.
